Price is syncing
Reported smart-money activity is still available below.
1 month
-1.0%
price return
Year to date
-0.4%
price return
Recent earnings
4/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
12 articles, 7 days
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Recent coverage and its overall tone.
News
Coverage leans bullish
5 bullish · 6 neutral · 1 bearish
Tone of tracked coverage
Travere Therapeutics Inc (TVTX) Institutional Confidence
Leans bullishJul 25TVTX|Travere Therapeutics Inc|Price:57.370|Chg%:+0.690
BullishJul 24Travere Therapeutics (TVTX) Gets a Buy from Guggenheim
BullishJul 23TVTX Stock On Track To Hit Near 20-Year Highs After Filspari Becomes The Only Approved FSGS Treatment
NeutralJul 23Travere Therapeutics, Inc. Stock 12‑Month Price Target Raised to $58.71, Implies 4% Upside
BullishJul 23RTRX5376243 Bond Profile — Key Metrics
NeutralJul 20Exploring High Growth Tech Stocks In The US For July 2026
Leans bullishJul 20RTRX5376243 Bond Risk Profile
NeutralJul 19Q1 2026 13F
$8.0M
position
AlphaYou
